BusinessAxsome Reports Accelerated AUVELITY Prescriptions for Alzheimer’s
Axsome Therapeutics (NASDAQ:AXSM) announced accelerating prescription growth for its Alzheimer’s drug AUVELITY. This increase follows the company’s expansion of its sales force, which has helped gain traction in the market. Executives highlighted the positive momentum as the launch progresses, indicating growing adoption of AUVELITY among healthcare providers treating Alzheimer’s disease.
Yahoo! News·


